Skip to main content

GE HealthCare Technologies Inc. income statement

  • GEHC · Nasdaq
  • Medical devices
  • Health Care Equipment
  • S&P 500
$83.02+1.44%Close 13 Nov 2026 · Market value $37.72B

GE HealthCare Technologies Inc. reported revenue of $20.6 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 4.8% from fiscal 2024. Net income was $2.08 billion and diluted earnings per share $4.55.

From GE HealthCare Technologies Inc.'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

GE HealthCare Technologies Inc. income statement, annual
USDFY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$17.59B$18.34B$19.55B$19.67B$20.63B$21.64B
Revenue growth—+4.3%+6.6%+0.6%+4.8%—
Gross profit$7.17B$7.18B$7.92B$8.21B$8.25B$8.64B
Gross margin40.8%39.1%40.5%41.7%40.0%39.9%
Research and development$816.0M$1.03B$1.21B$1.31B$1.26B$1.31B
Selling, general and administrative$3.56B$3.63B$4.28B$4.27B$4.22B$4.45B
Operating expenses$4.38B$4.66B$5.49B$5.58B$5.49B$5.76B
Operating income$2.79B$2.52B$2.44B$2.63B$2.76B$2.89B
Operating margin15.9%13.8%12.5%13.3%13.4%13.3%
Interest expense$40.00M$77.00M$542.0M$504.0M$440.0M$437.0M
Income before tax$2.88B$2.51B$2.36B$2.58B$2.77B$2.77B
Income tax expense$600.0M$563.0M$743.0M$531.0M$614.0M$561.0M
Effective tax rate20.9%22.4%31.5%20.6%22.2%20.2%
Net income$2.25B$1.92B$1.57B$1.99B$2.08B$2.15B
Net margin12.8%10.4%8.0%10.1%10.1%10.0%
Net income to common shareholders$2.25B$1.92B$1.39B$1.99B$2.08B—
EPS · diluted$4.95$4.22$3.03$4.34$4.55$4.73
Diluted weighted average shares454M454M458M459M458M455M
Basic weighted average shares454M454M455M456M456M453M
EBITDA$3.42B$3.15B$3.04B$3.21B$3.34B$3.51B
EBITDA margin19.4%17.2%15.6%16.3%16.2%16.2%
Depreciation & amortization$625.0M$633.0M$610.0M$580.0M$578.0M$622.0M
Stock-based compensation$76.00M$67.00M$114.0M$125.0M$130.0M$152.0M
Dividends per share——$0.12$0.13$0.14$0.15

Quarterly

GE HealthCare Technologies Inc. income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$5.21B$4.65B$4.84B$4.86B$5.32B$4.78B$5.01B$5.14B$5.70B$5.13B$5.29B$5.51B
Gross profit$2.16B$1.90B$2.00B$2.03B$2.27B$2.01B$1.99B$1.99B$2.26B$1.98B$2.18B$2.22B
Gross margin41.4%40.9%41.4%41.7%42.8%42.1%39.6%38.7%39.7%38.5%41.2%40.3%
Research and development$315.0M$324.0M$327.0M$316.0M$344.0M$344.0M$302.0M$292.0M$323.0M$345.0M$323.0M$320.0M
Selling, general and administrative$1.15B$1.04B$1.07B$1.03B$1.13B$1.04B$1.03B$1.04B$1.11B$1.12B$1.12B$1.10B
Operating expenses$1.47B$1.36B$1.40B$1.35B$1.47B$1.38B$1.33B$1.34B$1.43B$1.46B$1.44B$1.42B
Operating income$689.0M$540.0M$608.0M$676.0M$801.0M$629.0M$654.0M$653.0M$827.0M$515.0M$739.0M$805.0M
Operating margin13.2%11.6%12.6%13.9%15.1%13.2%13.1%12.7%14.5%10.0%14.0%14.6%
Interest expense$131.0M$122.0M$131.0M$130.0M$121.0M$110.0M$113.0M$111.0M$105.0M$96.00M$114.0M$122.0M
Income before tax$609.0M$512.0M$578.0M$658.0M$834.0M$692.0M$613.0M$643.0M$821.0M$505.0M$693.0M$752.0M
Income tax expense$193.0M$124.0M$143.0M$168.0M$96.00M$104.0M$113.0M$179.0M$219.0M$94.00M$119.0M$129.0M
Effective tax rate31.7%24.2%24.7%25.5%11.5%15.0%18.4%27.8%26.7%18.6%17.2%17.2%
Net income$403.0M$374.0M$428.0M$470.0M$721.0M$564.0M$486.0M$446.0M$589.0M$389.0M$561.0M$615.0M
Net margin7.7%8.0%8.8%9.7%13.6%11.8%9.7%8.7%10.3%7.6%10.6%11.2%
Net income to common shareholders$403.0M$374.0M$428.0M$470.0M$721.0M———————
EPS · diluted$0.88$0.81$0.93$1.02$1.57$1.23$1.06$0.98$1.29$0.85$1.24$1.36
Diluted weighted average shares458M459M459M459M459M459M458M457M458M457M454M453M
Basic weighted average shares455M456M457M457M456M457M457M456M453M456M453M452M
EBITDA$833.0M$688.0M$757.0M$819.0M$941.0M$765.0M$802.0M$802.0M$973.0M$668.0M$899.0M$968.0M
EBITDA margin16.0%14.8%15.6%16.8%17.7%16.0%16.0%15.6%17.1%13.0%17.0%17.6%
Depreciation & amortization$144.0M$148.0M$149.0M$143.0M$140.0M$136.0M$148.0M$149.0M$146.0M$153.0M$160.0M$163.0M
Stock-based compensation$33.00M$34.00M$36.00M$22.00M$33.00M$22.00M$34.00M$38.00M$36.00M$35.00M$45.00M$36.00M
Dividends per share$0.03$0.03$0.03$0.03$0.04$0.04$0.00$0.07$0.04$0.04$0.04$0.04

The main figures as JSON and plain text. See data and methodology.

GEHC in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.